Aus antimicrobial use decreasing but not enough: report
27 August, 2021While antimicrobial use in the community is decreasing, overprescribing and inappropriate prescribing continue to be problematic.
Review of National Medicines Policy after 22 years
04 August, 2021For the first time since its development in 1999, Australia's National Medicines Policy is set for review.
Speed up pharmacy vaccine rollout to end lockdown, says report
21 July, 2021Accelerating the rollout of vaccines into pharmacies could help Australia reach its vaccination target of 80% up to two months faster than current projections.
Medicinal cannabis facility planned for Toowoomba
12 July, 2021Medibis has announced long-term plans to build a multi-million-dollar medicinal cannabis facility in Toowoomba, Queensland.
Metabolic hormone leptin linked to vaccine response
31 May, 2021 by Amy SarcevicReduced levels of the metabolic hormone leptin may be responsible for poor vaccine efficacy among certain individuals, according to a new study.
New COVID-19 vaccine completely blocks viral transmission
19 May, 2021 by Amy SarcevicAn Adelaide-based company has developed a COVID-19 vaccine that completely blocks viral transmission to individuals who lack immunity, as well as offering protection for those inoculated.
Historic PBS listing of cannabis for Dravet syndrome
10 May, 2021Epidyolex has been added to the Pharmaceutical Benefits Scheme (PBS) for the treatment of Dravet syndrome, a rare and drug-resistant form of epilepsy.
New national standard for intensive care pharmacists
05 May, 2021The standardised guidelines place pharmacists as key members of the multidisciplinary medical team caring for patients in the ICU.
Evidence urgently needed on how to safely withdraw patients from antidepressants
03 May, 2021 by Amy SarcevicResearchers at the Cochrane Collaboration reviewed 33 studies involving nearly 5000 participants, relating to antidepressant discontinuation.
The collaboration igniting malaria drug discovery
27 April, 2021Johnson & Johnson Innovation has facilitated a collaboration between WEHI and Janssen Pharmaceutica NV to ignite the development of antimalarial drug candidates.
Putting pharmacists where they're needed most
27 April, 2021 by Kristin Michaels, SHPA CEOSHPA will continue to advocate for investment in embedding geriatric medicine pharmacists as part of clinical pharmacy services for aged-care residents.
AstraZeneca vaccine myths debunked
14 April, 2021 by Amy SarcevicAustralians are being reminded that a causal relationship between blood clotting and adenovirus vector-based vaccines has still not been established, and that — should it be — the risk remains far lower than that of common medications.
New cell-based flu vaccine to be rolled out this month
07 April, 2021 by Amy SarcevicThis winter, for the first time, a new cell-based flu vaccine will be introduced in Australia, in a bid to boost the efficacy rates of national immunisation programs.
Pausing the vaccine rollout will claim, not protect, lives, says Professor
22 March, 2021 by Amy SarcevicCountries that have opted to pause the AstraZeneca vaccine amid unsubstantiated blood clotting fears are actively choosing to end lives, according to Professor Bruce Thompson.
Compulsory vaccines possible but unlikely, says law professor
08 March, 2021 by Amy SarcevicWhatever the government's intention, Prof Stewart believes a mandate should be the "final instrument" in its quest to roll out a vaccination program.
